Skip to content
TL

TAVEXIA LIFECARE

539519 BSE
₹1.17

Close ·

P/E
Not meaningful: loss-making over the last twelve months
View as Markdown
MCP
Close 4 Nov 2026 ₹1.17 +0.38 +48.1% 1Y
Start ₹0.79

Key Fundamentals

MicrocapRetailConsumer Services

Price-based figures at the close · EPS basis: Consolidated · TTM

ROCE
−0.11%
Debt to Equity
0.08
EPS (TTM)
₹0.00
Book Value
₹1.11
Market Cap
—
P/E (TTM)
Not meaningful: loss-making over the last twelve months
P/B
1.05
ROE
−0.57%
Dividend Yield
0.00%
EBITDA
₹80.00 L
52W High
₹1.25
52W Low
₹0.49

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

48 Average

Data confidence 91/100

Category scores

Quality
33
Poor
Returns, margins, earnings quality 22% weight
Valuation
35
Poor
Cheap vs sector & own history 24% weight
Growth
99
Strong
Sales & profit trajectory 9% weight
Financial Health
30
Poor
Solvency, leverage, coverage 9% weight
Momentum
99
Strong
Trend strength, vol-adjusted 12% weight
Ownership
38
Weak
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

3
  • Company is almost debt free.
  • Stock is trading at 1.06 times its book value
  • Debtor days have improved from 341 to 125 days.

Weaknesses

4
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Promoter holding is low: 6.39%
  • Company has a low return on equity of 4.64% over last 3 years.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bullish3610
OscillatorsBullish162
Moving AveragesStrong Bullish208

Key readings

RSI (14)
55.71
Neutral
MACD (12,26,9)
0.01
Bearish
SMA (50)
1.12
Bullish
SMA (200)
0.84
Bullish

As of

Growth Rate

From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
5Y+90.34%
3Y+144.32%
1Y+512.74%
TTM+446.98%

Net profit

Net profit growth by window
5Y−13.75%
3Y−27.45%
1Y−91.57%
TTMTurned to loss

Operating cash flow

Operating cash flow growth by window
5YOutflow widened by ₹13.75 Cr
3YOutflow widened by ₹12.87 Cr
1YTurned negative
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
5Y−66.89 pp
3Y−64.15 pp
1Y−78.28 pp
TTM−80.56 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2020₹0.43 Cr
Mar 2021₹1.29 Cr
Mar 2022₹1.54 Cr
Mar 2023₹2.21 Cr
Mar 2024₹3.55 Cr
Mar 2025₹5.26 Cr
Mar 2026₹32.23 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2020₹0.00 Cr
Mar 2021₹0.44 Cr
Mar 2022₹0.02 Cr
Mar 2023₹0.55 Cr
Mar 2024₹1.19 Cr
Mar 2025₹2.49 Cr
Mar 2026₹0.21 Cr

Quarterly Results

₹ Cr
539519 quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
0.59
0.46
1.52
0.79
0.7
1.56
1.96
1.05
1.22
16.84
5.69
8.5
0.64
Expenses
0.35
0.03
0.93
0.33
0.21
0.64
0.9
0.27
0.44
15.68
6.23
15.03
0.88
Operating Profit
0.24
0.43
0.59
0.46
0.49
0.92
1.06
0.78
0.78
1.16
−0.54
−6.53
−0.24
OPM %
40.68%
93.48%
38.82%
58.23%
70%
58.97%
54.08%
74.29%
63.93%
6.89%
−9.49%
−76.82%
−37.5%
Other Income
0
0
0
0
0.1
0.04
0
0.26
0
0.04
0
5.85
0.12
Interest
0
0
0
0
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.05
Depreciation
0.13
0.09
0.08
0.18
0.1
0.1
0.09
0.12
0.08
0.13
0.16
0.18
0.14
PBT
0.11
0.34
0.51
0.28
0.48
0.85
0.96
0.91
0.69
1.06
−0.71
−0.87
−0.31
Tax %
27.27%
20.59%
25.49%
75%
27.08%
27.06%
27.08%
7.69%
5.8%
25.47%
−1.41%
−18.39%
−48.39%
Net Profit
0.08
0.27
0.38
0.06
0.34
0.62
0.69
0.84
0.65
0.78
−0.7
−0.71
−0.16
EPS (₹)
0
0
0
0
0
0
0.01
0.01
0.02
0.02
−0.01
−0.01
0

Profit & Loss

₹ Cr
539519 profit and loss, annual, ₹ crore
Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
0.43
1.29
1.54
2.21
3.55
5.26
32.23
31.67
Expenses
0.36
0.63
1.44
1.14
1.58
1.97
37.3
37.82
Operating Profit
0.07
0.66
0.1
1.07
1.97
3.29
−5.07
−6.15
OPM %
16.28%
51.16%
6.49%
48.42%
55.49%
62.55%
−15.73%
−19.42%
Other Income
0
0
0
−0.06
−0.03
0.37
5.89
6.01
Interest
0.06
0.05
0.02
0.03
0.02
0.05
0.1
0.08
Depreciation
0.01
0.02
0.06
0.22
0.38
0.42
0.55
0.61
PBT
0
0.59
0.02
0.76
1.54
3.19
0.17
−0.83
Tax %
—
25.42%
0%
27.63%
22.08%
21.94%
−23.53%
—
Net Profit
0
0.44
0.02
0.55
1.19
2.49
0.21
−0.79
EPS (₹)
0
0
0
0
0
0.04
0.01
0
Div. Payout %
—
0%
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
539519 balance sheet, annual, ₹ crore
Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
—
3.2
3.2
8.05
12.05
19.25
38.36
Reserves
—
0.44
0.51
7.43
10.14
4.71
4.87
Borrowings
—
0.1
0.1
0.24
0.17
0.52
3.51
Other Liabilities
—
0.51
0.64
0.64
0.92
2.15
64.61
Total Liabilities
—
4.25
4.45
16.36
23.28
26.63
111
Fixed Assets
—
0
0.15
1.51
1.13
1.15
3.79
CWIP
—
0
0
0
0
0
0
Investments
—
0
0.03
8.13
10.89
10.89
12.75
Other Assets
—
4.25
4.27
6.72
11.26
14.59
94.81
Total Assets
—
4.25
4.45
16.36
23.28
26.63
111

Cash Flow

₹ Cr
539519 cash flow, annual, ₹ crore
Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
—
−0.59
−0.92
−1.47
−2.77
0.11
−14.34
Investing
—
−0.08
0.73
−9.68
−2.77
−0.48
−3.61
Financing
—
0.87
0.03
11.16
5.51
0.37
19.32
Net Cash Flow
—
0.2
−0.16
0.01
−0.03
0
1.37
Free Cash Flow
—
−0.67
−1.14
−3.05
−2.77
−0.37
−17.53
CFO/OP
—
−89
−920
−118
−123
25
282

Ratios

539519 financial ratios, annual
Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
—
385
457
499
512
385
125
Inventory Days
—
1,460
543
2,579
1,035
2,404
81.13
Days Payable
—
539
173
412
181
529
581
Cash Conversion Cycle
—
1,306
827
2,665
1,366
2,260
−375
Working Capital Days
—
450
822
960
1,039
843
285
ROCE %
—
—
1.06%
8.7%
8.35%
13.79%
−0.11%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view TAVEXIA LIFECARE insights

61 extracted metrics across FY12–FY27.

Shareholding Pattern

As of Sep 2026

  • Public 74.88%
  • Others 21.47%
  • Promoters 3.65%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about TAVEXIA LIFECARE

What does TAVEXIA LIFECARE LIMITED do?
Incorporated in 1980, Sattva Sukun Lifecare Ltd is in the business of the manufacturing & trading of Burners
Where is TAVEXIA LIFECARE LIMITED (TAVEXIA) listed?
TAVEXIA LIFECARE LIMITED trades under code 539519 on the BSE.
Which sector does TAVEXIA LIFECARE LIMITED belong to?
TAVEXIA LIFECARE LIMITED is classified under the Retail sector, in the Distributors industry.
What is the 52-week high and low of TAVEXIA LIFECARE LIMITED?
Over the last 52 weeks TAVEXIA LIFECARE LIMITED has traded between ₹0.49 and ₹1.25 as of 4 Nov 2026.
What is the Return on Equity (ROE) of TAVEXIA LIFECARE LIMITED?
TAVEXIA LIFECARE LIMITED reported a return on equity of -0.57%. Its debt-to-equity ratio is 0.08.

Company Information

Incorporated in 1980, Sattva Sukun Lifecare Ltd is in the business of the manufacturing & trading of Burners

Website mayukh.co.in
Listed 21 Jun 2018
Face Value ₹1

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/539519.md for TAVEXIA LIFECARE LIMITED: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Retail stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month